Holen Sie sich die Stockscreener-App
32.82
1.26%
-0.42
Handel nachbörslich:
32.49
-0.33
-1.01%
Schlusskurs vom Vortag:
$33.24
Offen:
$33.31
24-Stunden-Volumen:
1.12M
Relative Volume:
0.85
Marktkapitalisierung:
$2.83B
Einnahmen:
$191.42M
Nettoeinkommen (Verlust:
$-111.83M
KGV:
-24.76
EPS:
-1.3253
Netto-Cashflow:
$-76.77M
1W Leistung:
+15.36%
1M Leistung:
+15.91%
6M Leistung:
+28.05%
1J Leistung:
+0.00%
1-Tages-Spanne:
$32.47
$34.31
1-Wochen-Bereich:
$27.98
$34.31
52-Wochen-Spanne:
$20.13
$41.22
Heartflow Inc Stock (HTFL) Company Profile
Firmenname
Heartflow Inc
Sektor
Branche
Telefon
650-241-1221
Adresse
135 MAIN STREET, SUITE 1000, SAN FRANCISCO
Compare HTFL vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HTFL
Heartflow Inc
|
32.82 | 2.87B | 191.42M | -111.83M | -76.77M | -1.3253 |
VEEV
Veeva Systems Inc
|
162.17 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-28 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-09-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-02 | Eingeleitet | Piper Sandler | Overweight |
| 2025-09-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Heartflow Inc Aktie (HTFL) Neueste Nachrichten
Lobbying Update: $90,000 of HEARTFLOW INC. lobbying was just disclosed - Quiver Quantitative
HeartFlow Inc (HTFL) CEO John Farquhar Sells 22,562 Shares - GuruFocus
Heartflow CEO John Farquhar sells $643,017 in company stock - Investing.com UK
Heartflow CEO John Farquhar sells $643,017 in company stock By Investing.com - Investing.com India
Heartflow (HTFL) CEO Farquhar sells 22,562 shares under Rule 10b5-1 plan - Stock Titan
Piper Sandler reiterates Heartflow stock rating on plaque revenue - Investing.com UK
Piper Sandler Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $38 - Moomoo
[144] Heartflow, Inc. SEC Filing - Stock Titan
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? - AOL.com
Patent Infringement Lawsuit Alleges "Piracy" of AI-Driven Medical Technology - The National Law Review
A Look At HeartFlow (HTFL) Valuation As Analyst Fair Value Diverges From Current Share Price - Yahoo Finance
Stifel reiterates Heartflow stock rating on clinical data strength - Investing.com
Carlyle Group Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
TFC Financial Management, Inc.'s HeartFlow Inc(HTFL) Holding History - GuruFocus
HeartFlow Q1 earnings call highlights - MSN
12 West Capital Management LP's HeartFlow Inc(HTFL) Holding History - GuruFocus
A Quick Look at Today's Ratings for Heartflow(HTFL.US), With a Forecast Between $35 to $37 - Moomoo
Heartflow CMO Campbell Rogers sells $261,266 of common stock By Investing.com - Investing.com South Africa
Heartflow CMO Campbell Rogers sells $261,266 of common stock - Investing.com
Heartflow (HTFL) CMO sells 9,219 shares after option exercise under 10b5-1 plan - Stock Titan
Earnings call transcript: HeartFlow Q1 2026 beats EPS expectations, stock falls - Investing.com
Why HeartFlow’s Stock Is Suddenly Sinking Hard - TipRanks
HTFL (NASDAQ: HTFL) Form 144 lists 86,240,828-share resale; recent trades noted - Stock Titan
Why HeartFlow Stock Is Racing Higher Today - TipRanks
Companies Like HeartFlow (NASDAQ:HTFL) Are In A Position To Invest In Growth - Sahm
HTFL Maintained by Canaccord Genuity -- Price Target Lowered to $37 - GuruFocus
Bain Capital Life Sciences holds 12.18% in Heartflow (HTFL) - Stock Titan
Heartflow revenue up 41% to USD 52.6M in Q1 2026 - Medical Buyer
HeartFlow PT Raised to $35 as Strong Execution Meets Premium Valuation, Supporting Hold Rating - TipRanks
Canaccord lowers Heartflow stock price target on valuation despite strong results - Investing.com Nigeria
Canaccord lowers Heartflow stock price target on valuation despite strong results By Investing.com - Investing.com South Africa
Heartflow's Q1 2026 Beat: Is This the Turning Point for HTFL - Kavout
Heartflow, Inc. Stock 12‑Month Price Target Cut to $37, Implies 15% Upside - TradingView
HTFL SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
HeartFlow (HTFL) Reports Strong Q1 2026 Earnings with 41% Revenue Growth - GuruFocus
HTFL Adjusts FY26 Gross Margin Outlook Amid Strong Earnings Cons - GuruFocus
Heartflow Q1 Earnings Call Highlights - sharewise.com
Heartflow (HTFL) Reports Strong Q1 Revenue Growth - GuruFocus
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript Summary - Moomoo
Why HeartFlow Stock Is Falling Despite AI Momentum - TipRanks
Earnings call transcript: HeartFlow Q1 2026 beats EPS forecast - Investing.com
Earnings call transcript: HeartFlow Q1 2026 beats EPS forecast By Investing.com - Investing.com Nigeria
Transcript: HeartFlow Q1 2026 Earnings Conference Call - Benzinga
Heartflow Sees 2026 Rev $228M-$232M >HTFL - Moomoo
Heartflow 1Q Loss/Shr 32c >HTFL - Moomoo
Heartflow Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Heartflow Inc (NASDAQ:HTFL) Beats Q1 Estimates and Hikes Full-Year Outlook, But Stock Slips After Hours - ChartMill
Heartflow Q1 Adjusted Loss Narrows, Revenue Rises - marketscreener.com
Finanzdaten der Heartflow Inc-Aktie (HTFL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):